Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:18:06.487Z.
Calculation as of: 2026-10-06T16:18:06.487Z.
Quote observation: 2026-10-06T16:14:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c1171bf84d9e01e227179f4391907e0b7edeaef3f5f58c6a2b8957218a297583
PEG RATIO
N/A
NEXGEL, Inc.
Market Cap
$1.41M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| NEXGEL, Inc. (NXGL) | $1.41M | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.41M | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.47M | N/A |
| Curis, Inc. (CRIS)vs › | $1.48M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.36M | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.33M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.24M | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
